Update to NIAID Strategic Plan for COVID-19 Research

Building upon the growing knowledge base of SARS-CoV-2 and COVID-19, this update to the NIAID Strategic Plan for COVID-19 Research outlines research priorities critical to better understanding, treating and preventing SARS-CoV-2 and COVID-19 and its post-acute sequelae. The plan is structured on four updated strategic research priorities: Advance basic research on SARS-CoV-2 biology, pathogenesis, and transmission Identify and test promising COVID-19 therapeutics Develop and test next-generation COVID-19 and pan-coronavirus vaccine candidates Characterize, prevent, and treat post-acute sequelae of SARS-CoV-2 infection (PASC) National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107